ES8704967A1 - Procedimiento para la obtencion de un 9alfa, 11alfa-epoxiesteroide. - Google Patents
Procedimiento para la obtencion de un 9alfa, 11alfa-epoxiesteroide.Info
- Publication number
- ES8704967A1 ES8704967A1 ES544387A ES544387A ES8704967A1 ES 8704967 A1 ES8704967 A1 ES 8704967A1 ES 544387 A ES544387 A ES 544387A ES 544387 A ES544387 A ES 544387A ES 8704967 A1 ES8704967 A1 ES 8704967A1
- Authority
- ES
- Spain
- Prior art keywords
- alpha
- epoxy
- epoxy steroids
- spirox
- hyperaldosteronism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000003431 steroids Chemical class 0.000 title abstract 2
- 239000004593 Epoxy Substances 0.000 title 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 1
- 239000005977 Ethylene Substances 0.000 abstract 1
- 206010020571 Hyperaldosteronism Diseases 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004980 cyclopropylene group Chemical group 0.000 abstract 1
- 239000002934 diuretic Substances 0.000 abstract 1
- 229940030606 diuretics Drugs 0.000 abstract 1
- 201000009395 primary hyperaldosteronism Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
- C07J53/008—3 membered carbocyclic rings in position 15/16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
- C07J71/0015—Oxiranes at position 9(11)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH300984 | 1984-06-21 | ||
| CH464684 | 1984-09-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES544387A0 ES544387A0 (es) | 1987-04-16 |
| ES8704967A1 true ES8704967A1 (es) | 1987-04-16 |
Family
ID=25691934
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES544387A Expired ES8704967A1 (es) | 1984-06-21 | 1985-06-20 | Procedimiento para la obtencion de un 9alfa, 11alfa-epoxiesteroide. |
| ES557112A Expired ES8707737A1 (es) | 1984-06-21 | 1986-10-01 | Procedimiento para la obtencion de una 9 l 11 l epoxiesteroide |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES557112A Expired ES8707737A1 (es) | 1984-06-21 | 1986-10-01 | Procedimiento para la obtencion de una 9 l 11 l epoxiesteroide |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4670551A (en:Method) |
| EP (1) | EP0165902B1 (en:Method) |
| AR (2) | AR242036A1 (en:Method) |
| AU (1) | AU582754B2 (en:Method) |
| CA (1) | CA1239388A (en:Method) |
| DE (1) | DE3569540D1 (en:Method) |
| DK (1) | DK173854B1 (en:Method) |
| ES (2) | ES8704967A1 (en:Method) |
| FI (1) | FI83225C (en:Method) |
| GR (1) | GR851499B (en:Method) |
| HU (1) | HU192232B (en:Method) |
| IE (1) | IE58050B1 (en:Method) |
| IL (1) | IL75569A (en:Method) |
| NO (1) | NO165496C (en:Method) |
| NZ (1) | NZ212492A (en:Method) |
| PT (1) | PT80663B (en:Method) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA009176B1 (ru) * | 1995-12-11 | 2007-12-28 | Дж.Д.Серл Энд Ко. | Способ получения 7-альфа-карбоксил-9,11-эпоксистероидов и промежуточных продуктов, используемых для их получения, и общий способ эпоксидирования по олефиновым двойным связям |
| ATE375992T1 (de) | 1996-12-11 | 2007-11-15 | Searle Llc | Epoxidierungsverfahren |
| US6887991B1 (en) | 1996-12-11 | 2005-05-03 | G. D. Searle & Company | Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein |
| EP1223174A3 (en) * | 1996-12-11 | 2005-03-16 | G.D. Searle & Co. | Processes for preparation of 3-keto-7alpha-alkoxycarbonyl-delta-4,5- steroids and intermediates useful therein |
| ES2347027T3 (es) | 1998-05-22 | 2010-10-22 | The Board Of Trustees Of The Leland Stanford Junior University | Moleculas bifuncionales y terapias basadas en las mismas. |
| WO2003049745A1 (en) | 2001-12-12 | 2003-06-19 | Pharmacia Corporation | Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists |
| US7235655B2 (en) | 2002-03-22 | 2007-06-26 | Pharmacia & Upjohn Company | Processes to prepare eplerenone |
| EP3827747A1 (en) | 2005-04-28 | 2021-06-02 | Otsuka Pharmaceutical Co., Ltd. | Pharma-informatics system |
| WO2007025780A2 (en) * | 2005-09-02 | 2007-03-08 | Recordati Ireland Limited | Aldosterone receptor antagonists |
| US9062126B2 (en) | 2005-09-16 | 2015-06-23 | Raptor Pharmaceuticals Inc. | Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof |
| PT3395372T (pt) | 2009-02-20 | 2022-05-05 | Enhanx Biopharm Inc | Sistema de entrega de medicamentos à base de glutationa |
| KR101741629B1 (ko) | 2009-05-06 | 2017-05-31 | 라보라토리 스킨 케어, 인크. | 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3013012A (en) * | 1960-12-22 | 1961-12-12 | Searle & Co | Alkanoylthio-17alpha-carboxyethyl-17beta-hydroxyandrosten-3-one lactones |
| US3095412A (en) * | 1961-12-19 | 1963-06-25 | Searle & Co | 9alpha, 11alpha-epoxy and 11beta-chloro-9alpha-hydroxy 17alpha-(2-carboxyethyl)-17beta-hydroxyandrost-4-en-3-one gamma-lactones and delta1 and delta6 analogs |
| GB1041534A (en) * | 1963-04-24 | 1966-09-07 | Merck & Co Inc | 20-spiroxane compounds |
| DE2652761C2 (de) * | 1976-11-16 | 1985-11-21 | Schering AG, 1000 Berlin und 4709 Bergkamen | 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| US4559332A (en) * | 1983-04-13 | 1985-12-17 | Ciba Geigy Corporation | 20-Spiroxanes and analogues having an open ring E, processes for their manufacture, and pharmaceutical preparations thereof |
| EP0134529B1 (de) * | 1983-08-17 | 1990-03-21 | Schering Aktiengesellschaft | 7-alpha-Substituierte 3-Oxo-17alpha-pregn-4-en-21.17-carbolactone, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate |
-
1985
- 1985-06-13 US US06/744,444 patent/US4670551A/en not_active Expired - Fee Related
- 1985-06-17 DE DE8585810277T patent/DE3569540D1/de not_active Expired
- 1985-06-17 EP EP85810277A patent/EP0165902B1/de not_active Expired
- 1985-06-19 PT PT80663A patent/PT80663B/pt not_active IP Right Cessation
- 1985-06-19 IL IL75569A patent/IL75569A/xx not_active IP Right Cessation
- 1985-06-19 GR GR851499A patent/GR851499B/el unknown
- 1985-06-19 CA CA000484418A patent/CA1239388A/en not_active Expired
- 1985-06-19 FI FI852430A patent/FI83225C/fi not_active IP Right Cessation
- 1985-06-20 NZ NZ212492A patent/NZ212492A/xx unknown
- 1985-06-20 NO NO852501A patent/NO165496C/no unknown
- 1985-06-20 HU HU852433A patent/HU192232B/hu not_active IP Right Cessation
- 1985-06-20 DK DK198502800A patent/DK173854B1/da not_active IP Right Cessation
- 1985-06-20 IE IE153585A patent/IE58050B1/en not_active IP Right Cessation
- 1985-06-20 ES ES544387A patent/ES8704967A1/es not_active Expired
- 1985-06-21 AR AR85300773A patent/AR242036A1/es active
- 1985-06-21 AU AU43971/85A patent/AU582754B2/en not_active Ceased
-
1986
- 1986-10-01 ES ES557112A patent/ES8707737A1/es not_active Expired
-
1989
- 1989-07-31 AR AR89314546A patent/AR245731A1/es active
Also Published As
| Publication number | Publication date |
|---|---|
| AU4397185A (en) | 1986-01-02 |
| PT80663B (en) | 1987-05-08 |
| AR242036A1 (es) | 1993-02-26 |
| DE3569540D1 (en) | 1989-05-24 |
| FI83225C (fi) | 1991-06-10 |
| EP0165902A3 (en) | 1986-10-22 |
| IL75569A (en) | 1989-03-31 |
| DK173854B1 (da) | 2001-12-27 |
| DK280085A (da) | 1985-12-22 |
| IL75569A0 (en) | 1985-10-31 |
| HUT38367A (en) | 1986-05-28 |
| NO852501L (no) | 1985-12-23 |
| ES544387A0 (es) | 1987-04-16 |
| IE58050B1 (en) | 1993-06-16 |
| IE851535L (en) | 1985-12-21 |
| HU192232B (en) | 1987-05-28 |
| NO165496C (no) | 1991-02-20 |
| DK280085D0 (da) | 1985-06-20 |
| CA1239388A (en) | 1988-07-19 |
| EP0165902A2 (de) | 1985-12-27 |
| AR245731A1 (es) | 1994-02-28 |
| ES8707737A1 (es) | 1987-08-16 |
| NZ212492A (en) | 1989-02-24 |
| NO165496B (no) | 1990-11-12 |
| US4670551A (en) | 1987-06-02 |
| AU582754B2 (en) | 1989-04-13 |
| FI852430L (fi) | 1985-12-22 |
| FI852430A0 (fi) | 1985-06-19 |
| FI83225B (fi) | 1991-02-28 |
| ES557112A0 (es) | 1987-08-16 |
| PT80663A (en) | 1985-07-01 |
| EP0165902B1 (de) | 1989-04-19 |
| GR851499B (en:Method) | 1985-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8607252A1 (es) | Procedimiento para preparar derivados de imidazol | |
| ES8704967A1 (es) | Procedimiento para la obtencion de un 9alfa, 11alfa-epoxiesteroide. | |
| IL74066A (en) | 6,6-ethylene-15,16-methylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactones,processes for the production thereof and pharmaceutical preparations containing them | |
| IL77668A (en) | Production of cholecalciferol derivatives and novel intermediates used therefor | |
| DE3563971D1 (en) | 1-alpha, 2-alpha-methylene-6-methylene and 6-alpha-methyl pregnenes, process for their preparation and pharmaceutical compositions containing them | |
| ES8400416A1 (es) | Procedimiento para la fabricacion de acil-2 hexahidro-1,3,4,6,7,11b-2h-piracino (2,1-a) isoquinoleinonas-4 e intermediarios. | |
| DE3265509D1 (en) | Process for the preparation of cholesterol derivatives, and intermediate derivatives therefor | |
| CA1262912C (en) | TETRAHYDROFURANYLIC SUBSTITUTION DERIVATIVES OF PROSTAGLANDIN ANALOGS | |
| GR3004059T3 (en:Method) | ||
| GR81987B (en:Method) | ||
| MY101961A (en) | 4-nitrogen substituted isoquinolinol compounds having cardiotonic, phosphodiesterease fraction iii inhibiting properties and/or renal vasodilating properties | |
| GB1530837A (en) | 3beta-(1-alkoxyethoxy)-steroids and their use in the production of steroids from sarsaponin | |
| AU548803B2 (en) | New n-substituted polyglycidyl urazole compounds, processes for their production and pharmaceutical preparations | |
| PT80471B (en) | Process for the preparation of 1-<3,4-dimetoxiphenetyl-amino>- 3-(m-tolyoxi)-2-propanol (bevantolol) | |
| GR3005847T3 (en:Method) | ||
| GR78213B (en:Method) | ||
| Clair-Tisdall | The Sources of Islam | |
| JPS51125362A (en) | Process for synthesizing echinatin glycosides | |
| WO1988001276A3 (en) | PROCESS FOR PRODUCING (Z)-17alpha-HALOGENVINYLSTEROIDS | |
| DE3361410D1 (en) | Nonapeptide having an immunostimulating activity, process for its preparation and its use | |
| GB1504133A (en) | 2-bromo-6beta-fluoro-pregnane compounds | |
| PL237058A1 (en) | Process for preparing 9/11-dehydroderivatives of steroidseries of pregnane from 11 alpha,21-dihydroxyderivatives | |
| SU1121940A1 (ru) | Этиловый эфир [3-метил-5- 2′ -оксифенил)-1,2,4-триазолил-1] уксусной кислоты, обладающий психостимулирующим действием | |
| SU1253113A1 (ru) | Способ получения цис-1,4-полибутадиена | |
| JPS5283520A (en) | Novel 2-arylthio-cyclopentanones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1A | Transfer granted | ||
| FD1A | Patent lapsed |
Effective date: 20041004 |